Journals / Annals of Medical Research / 2021 / Cilt: 28 - Sayı: 12

Computed tomography and magnetic resonance imaging features for differentiating functioning from non-functioning adrenal lesions

Pages
2207–2212
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Results: In patients with functioning adrenal mass, adenoma size (p:0.001), unenhanced and early-enhanced Hounsfield units (HU) (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: It is not well known whether the radiological features of adenomas differ between functioning and non-functioning adrenal lesions (NFAL).
📊
Key Findings & Data:Material and Methods: This retrospective study included 89 patients with functioning adrenal lesions and 148 patients with NFAL, whose CT or MRI findings were present.
💡
Conclusion & Impact:Results: In patients with functioning adrenal mass, adenoma size (p:0.001), unenhanced and early-enhanced Hounsfield units (HU) (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aim: It is not well known whether the radiological features of adenomas differ between functioning and non-functioning adrenal lesions (NFAL). The aim of this study was to evaluate the characteristic features of computed tomography (CT) and magnetic resonance imaging (MRI) characteristics among functioning and non-functioning adrenal lesions. Material and Methods: This retrospective study included 89 patients with functioning adrenal lesions and 148 patients with NFAL, whose CT or MRI findings were present. Group 1 included patients with functioning adrenal lesions and group 2 patients with NFAL. Results: In patients with functioning adrenal mass, adenoma size (p:0.001), unenhanced and early-enhanced Hounsfield units (HU) (p

🔖

Cite This Article

BERKER, D., GULER, S., TUNA, M. M., IMGA, N. N., KÖSEOĞLU, D., AYÇİÇEK, B., BASARAN, M. N., SENEL, C., TUNCEL, A. (2022). Computed tomography and magnetic resonance imaging features for differentiating functioning from non-functioning adrenal lesions. Annals of Medical Research, Cilt: 28 - Sayı: 12, 2207–2212. https://ajindex.com/articles/445920

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Young WF Jr. Clinical Practice. The incidentally discovered adrenal mass. N Engl J Med 2007;356:601- 10
  2. Davenport C, Liew A, Doherty B, et al. The prevalence of adrenal incidentaloma in routine clinical practice. Endocr 2011;40:80-3
  3. Szász P, Kučera P, Čtvrtlík F, et al. Diagnostic Value of Unenhanced CT Attenuation and CT Histogram Analysis in Differential Diagnosis of Adrenal Tumors. Medicina (Kaunas) 2020; 56:597
  4. Zeiger MA, Thompson GB, Duh QY, et al. The American Association of Clinical Endocrinologists and American Association of Endocrine Surgeons medical guidelines for the management of adrenal incidentalomas. Endocr Pract 200915:1-20
  5. Mantero F, Terzolo M, Arnaldi G, et al. A survey on adrenal incidentaloma in Italy. Study group on adrenal tumors of the Italian Society of Endocrinology. J Clin Endocrinol Metab 2000;85:637-44
  6. Reincke M, Nieke J, Krestin GP, et al. Preclinical Cushing’s Syndrome in Adrenal Incidentalomas: Comparison with adrenal Cushing’s Syndrome. J Clin Endocrinol Metab 1992;75:826-32
  7. Blake MA, Kalra MK, Sweeney AT, et al. Distinguishing benign from malignant adrenal masses: multidetector row CT proto-col with 10-minute delay. Radiol 2006;238:578-85
  8. Jason DS, Oltmann SC. Evaluation of an Adrenal Incidentaloma. Surg Clin North Am 2019;99:721-9
  9. Cawood TJ, Hunt PJ, O’Shea D, et al. Recommended evaluation of adrenal incidentalomas is costly, has high false-positive rates and confers a risk of fatal cancer that is similar to the risk of the adrenal lesion becoming malignant; time for a rethink? Eur J Endocrinol 2009;161:513-27
  10. Cho YY, Suh S, Joung JY, et al. Clinical characteristics and follow-up of Korean patients with adrenal incidentalomas. Korean J Intern Med 2013;28:557-64
  11. Terzolo M, Stigliano A, Chiodini I, et al; Italian Association of Clinical Endocrinologists. AME position statement on adrenal incidentaloma. European Eur J Endocrinol 2011;164:851-70
  12. Grumbach MM, Biller BMK, Braunstein GD, et al. Management of the clinically inapparent adrenal mass (“Incidentaloma”). Ann Intern Med 2003;138:424–9
  13. Barzon L, Scaroni C, Sonino N, et al. Risk factors and long-term follow-up of adrenal incidentalomas. J Clin Endocrinol Metab 1999;84:520-6
  14. Hamrahian AH, Ioachimescu AG, Remer EM, et al. Clinical utility of noncontrast computed tomography attenuation value ( ounsfield units) to differentiate adrenal adenomas/hyperplasias from nonadenomas: Cleveland Clinic experience. J Clin Endoc